Views & Analysis ASCO ’22 preview: Putting patients first For the first time since 2019, the American Society of Clinical Oncology (ASCO) annual meeting will be an in-person conference.
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
